Functional Ovarian Cysts - Exams and Tests
If you see your doctor for pelvic
pain or bleeding, you'll be checked for a number of conditions, including an
ovarian cyst, that may be causing your symptoms. Your
evaluation will include a
pelvic exam, a history of your symptoms and menstrual
periods, a family history, and a
transvaginal ultrasound (which uses a narrow wand
placed in the vagina). See a picture of
ovarian cysts
.
If your doctor discovers an ovarian cyst during a routine pelvic exam, a transvaginal or abdominal ultrasound can help show what kind of cyst it is.
When is further testing necessary?
If an ultrasound shows that you have a fluid-filled functional ovarian cyst, and it isn't causing you severe pain, your doctor will probably suggest a watchful waiting period. You can then have the cyst checked 6 to 8 weeks later to see whether it is changing in size. Most cysts go away without treatment in 1 to 2 months or after 1 to 2 menstrual periods. 3
Your doctor will recommend further testing or treatment if:
- Initial ultrasound doesn't clearly show what kind of cyst or growth is present, or both ovaries are affected.
- You are not ovulating during your initial examination (because you are either a postmenopausal woman or a girl not yet menstruating). Without ovulation, a new functional cyst would be highly unlikely, so other possible conditions are explored.
- You have moderate to severe pain or vaginal bleeding.
- A diagnosed functional ovarian cyst does not get smaller or go away in 2 to 3 months.
- An ovarian growth or cyst (mass) is larger than 3in.
- You have risk factors for ovarian cancer. The higher your risk of ovarian cancer, the more likely aggressive testing will be recommended to find out the cause of an ovarian mass.
Further testing
- Laparoscopy allows a surgeon to look at the ovary through a lighted viewing instrument and take a sample of the growth ( biopsy). After testing the sample, the surgeon can decide whether to surgically remove the cyst (cystectomy) or the entire ovary (oophorectomy). If there is concern about ovarian cancer, a laparotomy (instead of a laparoscopy) may be done. Then, if cancer is found, the surgeon can safely remove the ovaries.
- CA-125 (cancer antigen) test is only recommended for women with a very high risk for ovarian cancer. These are women with a significant family history of the disease. This blood test result is combined with ultrasound results, because it doesn't give a highly dependable diagnosis on its own.
WebMD Medical Reference from Healthwise
Functional Ovarian Cysts Topics
ENABLEX is a prescription medicine used in adults to treat the following symptoms due to a condition called overactive bladder:
- · having a strong need to go to the bathroom right away (also called "urgency")
- · leaks or wetting accidents (also called "urinary incontinence")
- · having to go to the bathroom too often (also called "urinary frequency")
IMPORTANT SAFETY INFORMATION
You should not take once-daily ENABLEX if you have certain types of stomach problems, glaucoma, or have trouble emptying your bladder. Side effects of ENBLEX include blurred vision, and more commonly dry mouth, constipation, indigestion, and abdominal pain. Use caution when doing certain activities until you know how ENBALEX affects you.
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRIPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.


